CRISPR Therapeutics Vertex Pharmaceuticals: Better Buy in 2026
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Determining which grocery store credit card is best for cash back requires comparing benefits. Find the right card to boost your rewards.
26,359 articlesInvestors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
Red Cat stock crashed today after the company announced a large share offering to raise capital. This piece breaks do...
Stocks with dividends are drawing buyers as growth slows. HDV and SPYD command big flows, yet risk signals suggest on...
AI infrastructure has reshaped markets, but not every stock fits every investor. This guide explains what CoreWeave d...
Investors are asking what's going with Uber stock as the company diversifies beyond ridesharing. This guide breaks do...
Oil markets face a persistent pricing regime, per Shell’s warning. This guide translates that view into practical inv...
NVIDIA and Micron delivered standout AI hardware results, but investors reacted differently as the AI demand mix shif...
How did xplr (xifr) perform in Q1 2026, and what does it mean for 2026 earnings guidance? This article breaks down th...
Looking to turn part of your savings into reliable monthly income? This guide breaks down how to earn $500 month from...
As Verastem prepares for its 2025 earnings outlook, investors should focus on cash runway, collaboration milestones, ...
As NetApp gears up for 2026 earnings, investors should focus on cloud services growth, margins, and free cash flow. T...
Investors are eyeing yuanbao (yb) 2026 earnings as the company pivots toward new revenue streams. This guide breaks d...